Masayoshi Ko

发表

Autonomic nervous system network and liver regeneration

S. Terai, K. Kamimura, Ryo Goto, 2018, World journal of gastroenterology.

Rare Mesenteric Arterial Diseases: Fibromuscular Dysplasia and Segmental Arterial Mediolysis and Literature Review

S. Terai, K. Kamimura, K. Tominaga, 2019, Internal medicine.

Effective prevention of sorafenib-related vascular damage induced adverse events and maintenance of hepatic function by dried bonito broth and histidine

S. Terai, K. Kamimura, S. Abe, 2019, Cancer management and research.

Effects of Atezolizumab and Bevacizumab on Adrenal Gland Metastasis of Hepatocellular Carcinoma: A Case Report and Review of Literature.

S. Terai, K. Kamimura, J. Yokoyama, 2022, Internal medicine.

Percutaneous transhepatic obliteration and percutaneous transhepatic sclerotherapy for intractable hepatic encephalopathy and gastric varices improves the hepatic function reserve.

Hiroki Sato, T. Ishikawa, A. Iwanaga, 2017, Biomedical reports.

Ghrelin‐insulin‐like growth factor‐1 axis is activated via autonomic neural circuits in the non‐alcoholic fatty liver disease

S. Terai, K. Kamimura, M. Ueno, 2020, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver

S. Terai, K. Kamimura, Itsuo Nagayama, 2021, Disease Models & Mechanisms.

Letrozole ameliorates liver fibrosis through the inhibition of the CTGF pathway and 17β-hydroxysteroid dehydrogenase 13 expression

S. Terai, K. Kamimura, K. Ohyama, 2022, Journal of Gastroenterology.

Cytapheresis for pyoderma gangrenosum associated with inflammatory bowel disease: A review of current status.

Hiroki Sato, S. Terai, K. Kamimura, 2020, World journal of clinical cases.

Cyclin D1 Binding Protein 1 Responds to DNA Damage through the ATM–CHK2 Pathway

Shujiro Okuda, M. Ohtsuka, S. Terai, 2022, Journal of clinical medicine.

Inhibition of sodium glucose cotransporter 2 (SGLT2) delays liver fibrosis in a medaka model of nonalcoholic steatohepatitis (NASH)

H. Nishina, S. Terai, K. Kamimura, 2019, FEBS open bio.

A case of hepatic inflammatory pseudo-tumor of the liver mimicking a metastatic tumor of colon and/or bile duct cancer

T. Ishikawa, K. Nishikura, A. Iwanaga, 2017 .

Rare Mesenteric Arterial Diseases: A Case Report of Fibromuscular Dysplasia and Segmental Arterial Mediolysis and Literature Review

S. Terai, K. Kamimura, K. Tominaga, 2019 .

Diagnosis and management of fibromuscular dysplasia and segmental arterial mediolysis in gastroenterology field: A mini-review

S. Terai, K. Kamimura, K. Tominaga, 2018, World journal of gastroenterology.

Evaluation of the branched-chain amino acid-to-tyrosine ratio prior to treatment as a prognostic predictor in patients with liver cirrhosis

T. Ishikawa, A. Iwanaga, K. Seki, 2017, Oncotarget.

Effect of treatment support on preventing local recurrence of hepatocellular carcinoma directly adjacent to the diaphragm.

T. Ishikawa, A. Iwanaga, K. Seki, 2017, Molecular and clinical oncology.

Effect of Lenvatinib on a Hepatocellular Carcinoma with Fibroblast Growth Factor Receptor 4 Expression: A Case Report and Review of the Literature

S. Terai, S. Morita, Takeshi Mizusawa, 2020, Internal medicine.

Complementary role of peripheral and central autonomic nervous system on insulin-like growth factor-1 activation to prevent fatty liver disease.

Itsuo Nagayama, Takashi Owaki, Yuto Tanaka, 2023, Hepatology international.